# Apotex Inc. – FDA Inspection, Jun 14, 2017

Source: https://www.keypedia.com/records/fda_inspections/apotex-inc/cdb79898-0a6b-44c3-803f-1591c1dab0be
Source feed: FDA_Inspections

> FDA inspection 1014399 of Apotex Inc., June 14, 2017. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 10 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1014399
- Company Name: Apotex Inc.
- Inspection Date: 2017-06-14
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Generic Drug Evaluation
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1340300 - 2026-09-25
- [FDA Inspection 1269753 - 2025-07-31](https://www.keypedia.com/records/fda_inspections/apotex-inc/97a6f469-c215-4e98-989c-8fcd9419767a)
- FDA Inspection 1187415 - 2022-09-23
- FDA Inspection 1096465 - 2019-06-19
- FDA Inspection 1055197 - 2018-05-10

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/hala-l-selby/4b507d3e-3d23-4c0c-97d4-495a25dc3947)
- [Issuing Officer](https://www.keypedia.com/people/laurimer-kuilan-torres/a7f49e33-9d35-4dfe-8bcc-d369d3834ef4)

Company: https://www.keypedia.com/companies/apotex-inc/014ba53e-d2d8-4cf9-9b1f-ae5074083865

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c